This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (55)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Calvin C. Linnemann, Jr, MD; M. Roy First, MD; Gerald Schiffman, PhD

Arch Intern Med. 1981;141(12):1637-1640.

Abstract
• Because of the risk of serious pneumococcal infections in patients receiving a renal transplant, a study was undertaken to determine if pneumococcal vaccine could be administered before or after transplantation. Vaccine was given to recipients of transplants and to patients who were undergoing dialysis. Both groups responded to the vaccine, and although the mean antibody levels were lower than those reported for normal populations, the levels were in the range thought to be protective for most pneumococcal types. Antibody levels, both before and after vaccination, were substantially lower in patients with recent transplants than in patients who were undergoing hemodialysis. Patients who are awaiting renal transplantation can be immunized while they are undergoing hemodialysis. Further study is needed to determine how long antibody levels will persist after vaccination in both patients undergoing hemodialysis and those receiving a transplant.

(Arch Intern Med 1981;141:1637-1640)

Author Affiliations
From the Department of Internal Medicine, University of Cincinnati College of Medicine (Drs Linnemann and First), and the Department of Microbiology and Immunology, State University of New York, Brooklyn (Dr Schiffman).

Footnotes
Accepted for publication Oct 6, 1980.

Reprint requests to Infectious Disease Division, Seventh Floor, University of Cincinnati College of Medicine, 231 Bethesda Ave, Cincinnati, OH 45267 (Dr Linnemann).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Vaccination and chronic kidney disease
Janus et al.
Nephrol Dial Transplant 2008;23:800-807.
FULL TEXT  

Safety and Immunogenicity of the American Academy of Pediatrics-Recommended Sequential Pneumococcal Conjugate and Polysaccharide Vaccine Schedule in Pediatric Solid Organ Transplant Recipients
Lin et al.
Pediatrics 2005;116:160-167.
ABSTRACT | FULL TEXT  

Vaccinations for Adult Solid-Organ Transplant Recipients: Current Recommendations and Protocols
Duchini et al.
Clin. Microbiol. Rev. 2003;16:357-364.
ABSTRACT | FULL TEXT  

Use of Licensed Vaccines for Active Immunization of the Immunocompromised Host
Pirofski and Casadevall
Clin. Microbiol. Rev. 1998;11:1-26.
ABSTRACT | FULL TEXT  

Infection in Solid Organ Transplantation: Prophylactic Regimens, Clinical Manifestations, and Empiric Therapy
Maudlin
Journal of Pharmacy Practice 1997;10:90-100.
ABSTRACT  

Revaccination of Renal Transplant and Hemodialysis Recipients With Pneumococcal Vaccine
Linnemann et al.
Arch Intern Med 1986;146:1554-1556.
ABSTRACT  

Pneumococcal Vaccine Efficacy in Selected Populations in the United States
BOLAN et al.
ANN INTERN MED 1986;104:1-6.
ABSTRACT  

Pneumococcal Vaccine: Clinical Efficacy and Effectiveness
SCHWARTZ
ANN INTERN MED 1982;96:208-220.
ABSTRACT